CrownBio - Translating Biology Into Medicine
  • Metabolic disease
    • In vitro biology
    • In vivo pharmacology
      • Obesity & diabetes
      • Cardiovascular disease
    • Translational research
  • ABOUT US
  • THE BUZZ
  • Updates
  • Events
  • News
  • Job Posting
  • FAQ
  • CONTACT
  • Cancer Biology
  • Metabolic Disease
  • Drug Design
  • Biotherapeutics

In vivo pharmacology

Tuesday, 21 June 2011 08:01 frontend
E-mail Print PDF

Crown Bioscience supports in vivo discovery research for obesity, diabetes, and cardiovascular disease.  We offer drug evaluation services in a wide range of laboratory animal species, including: non-human primates, minipig, dog, rat and mouse. 

Our capabilities include:

    - Drug profiling on dose-response efficacy

    - Cardiac function assessment 

    - Lipid profile, free fatty acids, etc

    - Lean & fat mass

    - Body weight & food consumption

    - Insulin resistance index (HOMA)

    - Tolerance tests for

        Glucose (GTT): Glucose disposal rate

        Insulin (ITT): Insulin sensitivity or resistance

        Pyruvate (PTT): Hepatic glucose genesis

        Clamp studies

    - Safety pharmacology for potential side effects

    -  PK/PD analysis

    - Histopathology

 


Obesity & diabetes

 

Last Updated on Wednesday, 04 July 2012 06:19  

Copyright © 1999-2011 Crown Bio Science Inc. All Rights Reserved. - TEL:+1.855.827.6968 | Login